DLL3 expression and methylation are associated with lower-grade glioma immune microenvironment and prognosis
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved..
Notch signalling pathway, particularly its ligand delta-ligand 3 (DLL3), is important in glioma, however, little is known about DLL3 regulation and prognostic effects. Immunohistochemistry on a cohort of 163 gliomas revealed DLL3 upregulation in IDH1 mutant gliomas, where it was associated with a favourable prognosis (HR[95% CI]: 0.28[0.09-0.87]; p = 0.021). We investigated the epigenetic regulation of DLL3, and identified individual CpG sites correlating with DLL3 mRNA expression, which were significant prognostic markers in LGG. In silico analysis revealed that infiltrating immune cells significantly correlated with DLL3 expression, methylation and somatic copy number alterations. The prognostic effects of DLL3 expression was significantly affected by infiltration of immune cells. RNA Sequencing of 83 LGGs and GO Term analysis of differentially expressed genes showed that low DLL3 expression was related to ciliogenesis, which was confirmed by TCGA LGG analysis. Thus, DLL3 may play an important role in the immune microenvironment and prognosis of LGGs.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:114 |
---|---|
Enthalten in: |
Genomics - 114(2022), 2 vom: 01. März, Seite 110289 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Noor, Humaira [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 25.04.2022 Date Revised 31.05.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ygeno.2022.110289 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM336567057 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM336567057 | ||
003 | DE-627 | ||
005 | 20231225232432.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ygeno.2022.110289 |2 doi | |
028 | 5 | 2 | |a pubmed24n1121.xml |
035 | |a (DE-627)NLM336567057 | ||
035 | |a (NLM)35124175 | ||
035 | |a (PII)S0888-7543(22)00034-9 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Noor, Humaira |e verfasserin |4 aut | |
245 | 1 | 0 | |a DLL3 expression and methylation are associated with lower-grade glioma immune microenvironment and prognosis |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.04.2022 | ||
500 | |a Date Revised 31.05.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. | ||
520 | |a Notch signalling pathway, particularly its ligand delta-ligand 3 (DLL3), is important in glioma, however, little is known about DLL3 regulation and prognostic effects. Immunohistochemistry on a cohort of 163 gliomas revealed DLL3 upregulation in IDH1 mutant gliomas, where it was associated with a favourable prognosis (HR[95% CI]: 0.28[0.09-0.87]; p = 0.021). We investigated the epigenetic regulation of DLL3, and identified individual CpG sites correlating with DLL3 mRNA expression, which were significant prognostic markers in LGG. In silico analysis revealed that infiltrating immune cells significantly correlated with DLL3 expression, methylation and somatic copy number alterations. The prognostic effects of DLL3 expression was significantly affected by infiltration of immune cells. RNA Sequencing of 83 LGGs and GO Term analysis of differentially expressed genes showed that low DLL3 expression was related to ciliogenesis, which was confirmed by TCGA LGG analysis. Thus, DLL3 may play an important role in the immune microenvironment and prognosis of LGGs | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a DLL3 | |
650 | 4 | |a Delta-like ligand 3 | |
650 | 4 | |a IDH1 mutation | |
650 | 4 | |a Lower-grade glioma | |
650 | 4 | |a Notch signalling pathway | |
650 | 4 | |a Prognostic biomarker | |
650 | 7 | |a Biomarkers, Tumor |2 NLM | |
650 | 7 | |a DLL3 protein, human |2 NLM | |
650 | 7 | |a Intracellular Signaling Peptides and Proteins |2 NLM | |
650 | 7 | |a Ligands |2 NLM | |
650 | 7 | |a Membrane Proteins |2 NLM | |
700 | 1 | |a Whittaker, Shane |e verfasserin |4 aut | |
700 | 1 | |a McDonald, Kerrie L |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Genomics |d 1990 |g 114(2022), 2 vom: 01. März, Seite 110289 |w (DE-627)NLM012628867 |x 1089-8646 |7 nnns |
773 | 1 | 8 | |g volume:114 |g year:2022 |g number:2 |g day:01 |g month:03 |g pages:110289 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ygeno.2022.110289 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 114 |j 2022 |e 2 |b 01 |c 03 |h 110289 |